Intended Use :

The PSA Semi-quantitative Rapid Test is a lateral flow chromatographic immunoassay for the semi-quantitative detection of prostate specific antigen (PSA) in human whole blood, serum or plasma at a cut-off level of 4 ng/mL. It is intended to be used as a screening test and as an aid in the diagnosis of prostate cancer. 

Sample：

Serum/Plasma/Whole Blood

Operation Process:

Performance:

Relative Sensitivity: 100%, Relative Specificity: 99%, Overall Agreement: 98.5%

Infectious Disease Rapid Test Catalogue: